POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1VM1_A_TAZA504_1 (BETA-LACTAMASE SHV-1)	1lar	PROTEIN (LAR) (Homo sapiens)	3 / 3	ASP A1667 TYR A1668 GLU A1651	None	0.85A	19.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1VM1_A_TAZA504_1 (BETA-LACTAMASE SHV-1)	2buj	SERINE/THREONINE-PRO TEIN KINASE 16 (Homo sapiens)	3 / 3	ASP A  35 TYR A  33 GLU A  93	None	0.83A	22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1VM1_A_TAZA504_1 (BETA-LACTAMASE SHV-1)	2e9x	DNA REPLICATION COMPLEX GINS PROTEIN PSF1 (Homo sapiens)	3 / 3	ASP A  82 TYR A  79 GLU A 110	None	0.85A	22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1VM1_A_TAZA504_1 (BETA-LACTAMASE SHV-1)	2zqq	METHYLGLUTACONYL-COA HYDRATASE (Homo sapiens)	3 / 3	ASP A 265 TYR A 268 GLU A 132	None	0.74A	23.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1VM1_A_TAZA504_1 (BETA-LACTAMASE SHV-1)	3tw8	DENN DOMAIN-CONTAINING PROTEIN 1B RAS-RELATED PROTEIN RAB-35 (Homo sapiens)	3 / 3	ASP B  44 TYR B  37 GLU A  44	None	0.85A	21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1VM1_A_TAZA504_1 (BETA-LACTAMASE SHV-1)	5dc4	AS25 MONOBODY (Homo sapiens)	3 / 3	ASP B  32 TYR B  77 GLU B  51	None	0.85A	18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1VM1_A_TAZA504_1 (BETA-LACTAMASE SHV-1)	5tfm	CADHERIN-23 (Homo sapiens)	3 / 3	ASP A 727 TYR A 681 GLU A 607	CA  A 901 (-3.5A) None CA  A 902 ( 2.2A)	0.86A	15.23